FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285292278> ?p ?o ?g. }

• W4285292278 endingPage "127" @default.
• W4285292278 startingPage "118" @default.
• W4285292278 abstract "Immune-checkpoint inhibitor-based combination immunotherapy has become a first-line treatment for several major types of cancer including hepatocellular carcinoma (HCC), renal cell carcinoma, lung cancer, cervical cancer, and gastric cancer. Combination immunotherapy counters several immunosuppressive elements in the tumor microenvironment and activates multiple steps of the cancer-immunity cycle. The anti-PD-L1 antibody, atezolizumab, plus the anti-vascular endothelial growth factor antibody, bevacizumab, represents a promising class of combination immunotherapy. This combination has produced unprecedented clinical efficacy in unresectable HCC and become a landmark in HCC therapy. Advanced HCC patients treated with atezolizumab plus bevacizumab demonstrated impressive improvements in multiple clinical endpoints including overall survival, progress-free survival, objective response rate, and patient-reported quality of life when compared to current first-line treatment with sorafenib. However, atezolizumab plus bevacizumab first-line therapy has limitations. First, cancer patients falling into the criteria for the combination therapy may need to be further selected to reap benefits while avoiding some potential pitfalls. Second, the treatment regimen of atezolizumab plus bevacizumab at a fixed dose may require adjustment for optimal normalization of the tumor microenvironment to obtain maximum efficacy and reduce adverse events. Third, utilization of predictive biomarkers is urgently needed to guide the entire treatment process. Here we review the current status of clinically approved combination immunotherapies and the underlying immune mechanisms. We further provide a perspective analysis of the limitations for combination immunotherapies and potential approaches to overcome the limitations." @default.
• W4285292278 created "2022-07-14" @default.
• W4285292278 creator A5003759585 @default.
• W4285292278 creator A5008132835 @default.
• W4285292278 creator A5009198510 @default.
• W4285292278 creator A5023746467 @default.
• W4285292278 creator A5039010144 @default.
• W4285292278 creator A5039320907 @default.
• W4285292278 creator A5052561518 @default.
• W4285292278 creator A5063326455 @default.
• W4285292278 creator A5074197949 @default.
• W4285292278 creator A5077460838 @default.
• W4285292278 creator A5086232250 @default.
• W4285292278 date "2022-01-01" @default.
• W4285292278 modified "2023-10-14" @default.
• W4285292278 title "Clinically approved combination immunotherapy: Current status, limitations, and future perspective" @default.
• W4285292278 cites W1521700858 @default.
• W4285292278 cites W1603230122 @default.
• W4285292278 cites W1970986474 @default.
• W4285292278 cites W1971208896 @default.
• W4285292278 cites W1974956292 @default.
• W4285292278 cites W1978299567 @default.
• W4285292278 cites W1986665131 @default.
• W4285292278 cites W1994993231 @default.
• W4285292278 cites W1996106353 @default.
• W4285292278 cites W2000519725 @default.
• W4285292278 cites W2019837162 @default.
• W4285292278 cites W2020531037 @default.
• W4285292278 cites W2022540958 @default.
• W4285292278 cites W2039548371 @default.
• W4285292278 cites W2046623913 @default.
• W4285292278 cites W2065847476 @default.
• W4285292278 cites W2080202443 @default.
• W4285292278 cites W2080663543 @default.
• W4285292278 cites W2100106896 @default.
• W4285292278 cites W2103058588 @default.
• W4285292278 cites W2124427232 @default.
• W4285292278 cites W2127718637 @default.
• W4285292278 cites W2130210996 @default.
• W4285292278 cites W2134431790 @default.
• W4285292278 cites W2136587516 @default.
• W4285292278 cites W2136977965 @default.
• W4285292278 cites W2142104626 @default.
• W4285292278 cites W2147535764 @default.
• W4285292278 cites W2156012497 @default.
• W4285292278 cites W2166805191 @default.
• W4285292278 cites W2170181841 @default.
• W4285292278 cites W2275872217 @default.
• W4285292278 cites W2292212945 @default.
• W4285292278 cites W2322036524 @default.
• W4285292278 cites W2534772180 @default.
• W4285292278 cites W2560364793 @default.
• W4285292278 cites W2560367415 @default.
• W4285292278 cites W2601414401 @default.
• W4285292278 cites W2601868035 @default.
• W4285292278 cites W2606367731 @default.
• W4285292278 cites W2759997926 @default.
• W4285292278 cites W2787358630 @default.
• W4285292278 cites W2791328450 @default.
• W4285292278 cites W2795055433 @default.
• W4285292278 cites W2800280019 @default.
• W4285292278 cites W2800799386 @default.
• W4285292278 cites W2805354595 @default.
• W4285292278 cites W2805592007 @default.
• W4285292278 cites W2810928105 @default.
• W4285292278 cites W2888739032 @default.
• W4285292278 cites W2892757136 @default.
• W4285292278 cites W2911812451 @default.
• W4285292278 cites W2912648850 @default.
• W4285292278 cites W2913745075 @default.
• W4285292278 cites W2914098003 @default.
• W4285292278 cites W2943887705 @default.
• W4285292278 cites W2955008365 @default.
• W4285292278 cites W2963245811 @default.
• W4285292278 cites W2964882150 @default.
• W4285292278 cites W2977722669 @default.
• W4285292278 cites W2990602950 @default.
• W4285292278 cites W2999153903 @default.
• W4285292278 cites W3004987220 @default.
• W4285292278 cites W3008157853 @default.
• W4285292278 cites W3010512563 @default.
• W4285292278 cites W3016423312 @default.
• W4285292278 cites W3017091658 @default.
• W4285292278 cites W3023772547 @default.
• W4285292278 cites W3024389603 @default.
• W4285292278 cites W3025022288 @default.
• W4285292278 cites W3033218405 @default.
• W4285292278 cites W3041197920 @default.
• W4285292278 cites W3044786201 @default.
• W4285292278 cites W3045387409 @default.
• W4285292278 cites W3047999299 @default.
• W4285292278 cites W3093964219 @default.
• W4285292278 cites W3094496272 @default.
• W4285292278 cites W3094602125 @default.
• W4285292278 cites W3096339202 @default.
• W4285292278 cites W3100629716 @default.
• W4285292278 cites W3109638148 @default.
• W4285292278 cites W3112156481 @default.

• next